(VIANEWS) – Cutera (CUTR), Customers Bancorp (CUBI), MasTec (MTZ) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Cutera (CUTR)

40.4% sales growth and 15.25% return on equity

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide.

Cutera’s sales growth this year is anticipated to be 53.5% and 8.9% for next year.

Year-on-year quarterly revenue growth grew by 46.6%, now sitting on 215.58M for the twelve trailing months.

Volume

Today’s last reported volume for Cutera is 32403 which is 78.22% below its average volume of 148800.

Cutera’s sales growth for the next quarter is 40.4%. The company’s growth estimates for the ongoing quarter and the next is a negative 54.8% and negative -29.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.25%.

Volatility

Cutera’s last day, last week, and last month’s current intraday variation average was 4.67%, 4.44%, and 3.50%, respectively.

Cutera’s highest amplitude of average volatility was 8.64% (day), 7.97% (last week), and 6.57% (last month), respectively.

Cutera’s Stock Yearly Top and Bottom Value

Cutera’s stock is valued at $35.53 at 10:22 EST, way under its 52-week high of $60.36 and way higher than its 52-week low of $19.88.

Cutera’s Moving Average

Cutera’s worth is way below its 50-day moving average of $41.04 and way under its 200-day moving average of $41.50.

2. Customers Bancorp (CUBI)

28.5% sales growth and 20.82% return on equity

Customers Bancorp, Inc. operates as the bank holding company for Customers Bank that provides financial products and services to individual consumers, and small and middle market businesses.

Customers Bancorp’s sales growth this year is anticipated to be 44.2% and a negative 6% for next year.

Year-on-year quarterly revenue growth grew by 84%, now sitting on 605.61M for the twelve trailing months.

Volume

Today’s last reported volume for Customers Bancorp is 581952 which is 80.45% above its average volume of 322485.

Customers Bancorp’s sales growth for the next quarter is 28.5%. The company’s growth estimates for the present quarter and the next is 33.8% and 18.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.82%.

Volatility

Customers Bancorp’s last day, last week, and last month’s current intraday variation average was 0.89%, 1.82%, and 2.03%, respectively.

Customers Bancorp’s highest amplitude of average volatility was 3.38% (day), 3.96% (last week), and 3.64% (last month), respectively.

Customers Bancorp’s Stock Yearly Top and Bottom Value

Customers Bancorp’s stock is valued at $58.21 at 10:22 EST, under its 52-week high of $61.48 and way higher than its 52-week low of $17.32.

Customers Bancorp’s Moving Average

Customers Bancorp’s value is above its 50-day moving average of $53.22 and way above its 200-day moving average of $40.68.

3. MasTec (MTZ)

27.7% sales growth and 17.68% return on equity

MasTec, Inc., an infrastructure construction company, provides engineering, building, installation, maintenance, and upgrade services for communications, energy, utility, and other infrastructure primarily in the United States and Canada.

MasTec’s sales growth this year is expected to be 28.7% and 9.7% for next year.

Year-on-year quarterly revenue growth grew by 41.6%, now sitting on 7.78B for the twelve trailing months.

Volume

Today’s last reported volume for MasTec is 302264 which is 55.44% below its average volume of 678422.

MasTec’s sales growth is a negative 0% for the present quarter and 27.7% for the next. The company’s growth estimates for the present quarter and the next is a negative 7.7% and negative -24%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.68%.

Volatility

MasTec’s last day, last week, and last month’s current intraday variation average was 1.00%, 1.53%, and 2.45%, respectively.

MasTec’s highest amplitude of average volatility was 3.41% (day), 3.16% (last week), and 3.89% (last month), respectively.

MasTec’s Stock Yearly Top and Bottom Value

MasTec’s stock is valued at $87.98 at 10:22 EST, way below its 52-week high of $122.33 and way above its 52-week low of $65.18.

MasTec’s Moving Average

MasTec’s value is below its 50-day moving average of $91.78 and way below its 200-day moving average of $98.06.

Previous days news about MasTec(MTZ)

  • Mastec to acquire henkels & mccoy group for $600 mln cash, stock – quick facts. According to Business Insider on Monday, 20 December, "Total transaction consideration will be $600 million, with approximately $420 million in cash (including the repayment of Henkels’ debt) plus approximately 2 million shares of MasTec common stock, subject to customary purchase price adjustments. ", "The transaction has been unanimously approved by the Board of Directors of both MasTec and Henkels, as well as Henkels’ shareholders, and is expected to close by year end 2021, subject to receiving required Hart-Scott-Rodino approvals and the satisfaction of other customary closing conditions."

4. Opera Limited (OPRA)

16.7% sales growth and 9.23% return on equity

Opera Limited, together with its subsidiaries, provides mobile and PC web browsers.

Opera Limited’s sales growth this year is expected to be 50.8% and 16.5% for next year.

Year-on-year quarterly revenue growth grew by 57.1%, now sitting on 228.59M for the twelve trailing months.

Volume

Today’s last reported volume for Opera Limited is 87574 which is 39.07% below its average volume of 143733.

Opera Limited’s sales growth for the next quarter is 16.7%. The company’s growth estimates for the present quarter and the next is a negative 73.3% and 75%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.23%.

Volatility

Opera Limited’s last day, last week, and last month’s current intraday variation average was 4.56%, 3.00%, and 2.38%, respectively.

Opera Limited’s highest amplitude of average volatility was 6.11% (day), 5.48% (last week), and 5.39% (last month), respectively.

Opera Limited’s Stock Yearly Top and Bottom Value

Opera Limited’s stock is valued at $7.24 at 10:22 EST, way below its 52-week high of $13.93 and higher than its 52-week low of $6.80.

Opera Limited’s Moving Average

Opera Limited’s value is way below its 50-day moving average of $8.47 and way below its 200-day moving average of $9.86.

5. Anthem (ANTM)

15.2% sales growth and 15.84% return on equity

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States.

Anthem’s sales growth this year is expected to be 13.6% and 9.5% for next year.

Year-on-year quarterly revenue growth grew by 15%, now sitting on 133.88B for the twelve trailing months.

Volume

Today’s last reported volume for Anthem is 73836 which is 93.46% below its average volume of 1130390.

Anthem’s sales growth for the next quarter is 15.2%. The company’s growth estimates for the present quarter and the next is 52.4% and 105.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.84%.

Volatility

Anthem’s last day, last week, and last month’s current intraday variation average was 1.28%, 1.54%, and 1.33%, respectively.

Anthem’s highest amplitude of average volatility was 3.96% (day), 2.90% (last week), and 2.14% (last month), respectively.

Anthem’s Stock Yearly Top and Bottom Value

Anthem’s stock is valued at $444.61 at 10:22 EST, above its 52-week high of $439.90.

Anthem’s Moving Average

Anthem’s value is higher than its 50-day moving average of $413.11 and way higher than its 200-day moving average of $386.31.

6. Sempra Energy (SRE)

13.5% sales growth and 9.7% return on equity

Sempra Energy operates as an energy-services holding company in the United States and internationally.

Sempra Energy’s sales growth this year is anticipated to be 6.2% and 3.9% for next year.

Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 11.6B for the twelve trailing months.

Volume

Today’s last reported volume for Sempra Energy is 1359130 which is 9.56% below its average volume of 1502820.

Sempra Energy’s sales growth is a negative 0% for the ongoing quarter and 13.5% for the next. The company’s growth estimates for the current quarter and the next is 23.7% and 4.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.7%.

Volatility

Sempra Energy’s last day, last week, and last month’s current intraday variation average was 0.54%, 1.04%, and 0.74%, respectively.

Sempra Energy’s highest amplitude of average volatility was 2.81% (day), 2.23% (last week), and 1.50% (last month), respectively.

Sempra Energy’s Stock Yearly Top and Bottom Value

Sempra Energy’s stock is valued at $127.55 at 10:22 EST, way under its 52-week high of $144.93 and way higher than its 52-week low of $114.66.

Sempra Energy’s Moving Average

Sempra Energy’s value is below its 50-day moving average of $127.70 and below its 200-day moving average of $132.87.

7. Duke Energy (DUK)

11.7% sales growth and 5.65% return on equity

Duke Energy Corporation, together with its subsidiaries, operates as an energy company in the United States.

Duke Energy’s sales growth this year is expected to be 6.2% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 23.99B for the twelve trailing months.

Volume

Today’s last reported volume for Duke Energy is 208613 which is 92.66% below its average volume of 2843290.

Duke Energy’s sales growth is a negative 0% for the ongoing quarter and 11.7% for the next. The company’s growth estimates for the current quarter and the next is a negative 3.2% and negative -4.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.65%.

Volatility

Duke Energy’s last day, last week, and last month’s current intraday variation average was 0.61%, 1.42%, and 1.14%, respectively.

Duke Energy’s highest amplitude of average volatility was 1.91% (day), 2.16% (last week), and 1.72% (last month), respectively.

Duke Energy’s Stock Yearly Top and Bottom Value

Duke Energy’s stock is valued at $104.08 at 10:22 EST, below its 52-week high of $108.38 and way higher than its 52-week low of $85.56.

Duke Energy’s Moving Average

Duke Energy’s worth is above its 50-day moving average of $100.75 and above its 200-day moving average of $100.86.

8. Amedisys (AMED)

6.3% sales growth and 31.15% return on equity

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.

Amedisys’s sales growth this year is expected to be 8.8% and 9.5% for next year.

Year-on-year quarterly revenue growth grew by 16.3%, now sitting on 2.2B for the twelve trailing months.

Volume

Today’s last reported volume for Amedisys is 629884 which is 42.17% above its average volume of 443028.

Amedisys’s sales growth is a negative 0% for the ongoing quarter and 6.3% for the next. The company’s growth estimates for the current quarter and the next is a negative 39.3% and negative -2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.15%.

Volatility

Amedisys’s last day, last week, and last month’s current intraday variation average was 1.03%, 1.31%, and 2.78%, respectively.

Amedisys’s highest amplitude of average volatility was 5.45% (day), 3.45% (last week), and 4.74% (last month), respectively.

Amedisys’s Stock Yearly Top and Bottom Value

Amedisys’s stock is valued at $153.87 at 10:22 EST, way under its 52-week high of $325.12 and way higher than its 52-week low of $133.62.

Amedisys’s Moving Average

Amedisys’s value is under its 50-day moving average of $162.42 and way under its 200-day moving average of $217.22.

LEAVE A REPLY

Please enter your comment!
Please enter your name here